The Insulin in Dosage Market Size Value Per Capita in Slovakia has demonstrated a stable upward trend, reaching 13.6 USD in 2023. Over the last two years, the market recorded a modest increase of 1.5% from 2022. Over a five-year period, from 2018 to 2023, the compound annual growth rate (CAGR) is approximately 0.9%, indicating consistent growth in market value per capita.
Future trends to watch for include advancements in insulin delivery technologies, policy changes impacting diabetes care accessibility, and demographic shifts potentially affecting demand. Continuous innovation and healthcare policy adaptation will be crucial in shaping this market's evolution.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 11 | 11 New Zealand | 16.5 | 2023 | View data | ||
| 12 | 12 Slovenia | 16.43 | 2023 | View data | ||
| 13 | 13 Slovakia | 13.6 | 2023 | |||
| 14 | 14 Japan | 13.48 | 2023 | View data | ||
| 15 | 15 Lithuania | 12.65 | 2023 | View data | ||
